The role of PKC and PKD1 in processes that are relevant to neoplastic transformation, proliferation, apoptosis, and tumor cell invasion provides a potential suitable target for anticancer therapy [34,44,46], including glioma [6,9,10,11,12]. The gene discussed is PRRT2; the disease is glioma.